Secondary Logo

How can we improve our homepage? Let us know your ideas!


February 2019 - Volume 30 - Issue 2

  • Mels Sluyser, PhD
  • 0959-4973
  • 1473-5741
  • 10 / year
  • 181 of 217 Oncology
    187 of 256 Pharmacology & Pharmacy
  • 1.869

Current Issue Highlights


Cytotoxicity and molecular activity of fenretinide and metabolites in T-cell lymphoid malignancy, neuroblastoma, and ovarian cancer cell lines in physiological hypoxia

Song, Michael M.; Makena, Monish R.; Hindle, Ashly; More

Anti-Cancer Drugs. 30(2):117-127, February 2019.



Four lines of anaplastic lymphoma kinase inhibitors and brain radiotherapy in a long-surviving non-small-cell lung cancer anaplastic lymphoma kinase-positive patient with leptomeningeal carcinomatosis

Onesti, Concetta E.; Iacono, Daniela; Angelini, Silvia; More

Anti-Cancer Drugs. 30(2):201-204, February 2019.

`